News and culture through the lens of Southern California.
Hosted by A Martínez
Airs Weekdays 9 to 10 a.m.

Have California's stem-cell research efforts been worth the $3 billion price tag?




Close up of a screen which shows an injection of embryo stem cells in a mouse to set a genetically modified line, on February 9, 2012 in Marseille, France.
Close up of a screen which shows an injection of embryo stem cells in a mouse to set a genetically modified line, on February 9, 2012 in Marseille, France.
ANNE-CHRISTINE POUJOULAT/AFP/Getty Images

Listen to story

06:58
Download this story 3.0MB

Nearly a decade ago, voters here approved Proposition 71, the California Stem Cell Research and Cures Initiative. The initiative made conducting stem cell research legal and authorized the sale of bonds to generate $3 billion for stem cell research and research.

But now, most of that money has been spent and there are concerns about how the agency is being run. For more on this we're joined by David Jensen, a former reporter who's spent years covering the agency. He now runs a blog called the California Stem Cell Report